Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1995 1
1996 1
1999 2
2000 3
2001 3
2003 4
2005 1
2006 6
2007 5
2008 9
2009 9
2010 12
2011 10
2012 20
2013 17
2014 17
2015 15
2016 23
2017 18
2018 23
2019 24
2020 19
2021 35
2022 22
2023 16

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Results by year

Filters applied: . Clear all
Page 1
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial.
Scriba TJ, Fiore-Gartland A, Penn-Nicholson A, Mulenga H, Kimbung Mbandi S, Borate B, Mendelsohn SC, Hadley K, Hikuam C, Kaskar M, Musvosvi M, Bilek N, Self S, Sumner T, White RG, Erasmus M, Jaxa L, Raphela R, Innes C, Brumskine W, Hiemstra A, Malherbe ST, Hassan-Moosa R, Tameris M, Walzl G, Naidoo K, Churchyard G, Hatherill M; CORTIS-01 Study Team. Scriba TJ, et al. Among authors: walzl g. Lancet Infect Dis. 2021 Mar;21(3):354-365. doi: 10.1016/S1473-3099(20)30914-2. Epub 2021 Jan 25. Lancet Infect Dis. 2021. PMID: 33508224 Free PMC article. Clinical Trial.
T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection.
Musvosvi M, Huang H, Wang C, Xia Q, Rozot V, Krishnan A, Acs P, Cheruku A, Obermoser G, Leslie A, Behar SM, Hanekom WA, Bilek N, Fisher M, Kaufmann SHE, Walzl G, Hatherill M, Davis MM, Scriba TJ; Adolescent Cohort Study team; GC6-74 Consortium. Musvosvi M, et al. Among authors: walzl g. Nat Med. 2023 Jan;29(1):258-269. doi: 10.1038/s41591-022-02110-9. Epub 2023 Jan 5. Nat Med. 2023. PMID: 36604540 Free PMC article.
A blood RNA signature for tuberculosis disease risk: a prospective cohort study.
Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon LM, Mahomed H, Erasmus M, Whatney W, Hussey GD, Abrahams D, Kafaar F, Hawkridge T, Verver S, Hughes EJ, Ota M, Sutherland J, Howe R, Dockrell HM, Boom WH, Thiel B, Ottenhoff THM, Mayanja-Kizza H, Crampin AC, Downing K, Hatherill M, Valvo J, Shankar S, Parida SK, Kaufmann SHE, Walzl G, Aderem A, Hanekom WA; ACS and GC6-74 cohort study groups. Zak DE, et al. Among authors: walzl g. Lancet. 2016 Jun 4;387(10035):2312-2322. doi: 10.1016/S0140-6736(15)01316-1. Epub 2016 Mar 24. Lancet. 2016. PMID: 27017310 Free PMC article.
Helminth-M. tb co-infection.
du Plessis N, Walzl G. du Plessis N, et al. Among authors: walzl g. Adv Exp Med Biol. 2014;828:49-74. doi: 10.1007/978-1-4939-1489-0_3. Adv Exp Med Biol. 2014. PMID: 25253027 Review. No abstract available.
Diagnostic Challenge of Tuberculosis Heterogeneity.
Nemes E, Meermeier EW, Scriba TJ, Walzl G, Malherbe ST, Lewinsohn DM. Nemes E, et al. Among authors: walzl g. Semin Respir Crit Care Med. 2018 Jun;39(3):286-296. doi: 10.1055/s-0038-1660471. Epub 2018 Aug 2. Semin Respir Crit Care Med. 2018. PMID: 30071544 Review.
Immunological biomarkers of tuberculosis.
Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A. Walzl G, et al. Nat Rev Immunol. 2011 May;11(5):343-54. doi: 10.1038/nri2960. Epub 2011 Apr 8. Nat Rev Immunol. 2011. PMID: 21475309 Review.
283 results